Characterization of Senescence of Culture-expanded Human Adipose-derived Mesenchymal Stem Cells.
10.15283/ijsc.2016.9.1.124
- Author:
Diana LEGZDINA
1
;
Anete ROMANAUSKA
;
Sergey NIKULSHIN
;
Tatjana KOZLOVSKA
;
Uldis BERZINS
Author Information
1. Latvian Biomedical Research and Study Centre, Riga, Latvia. dianal@biomed.lu.lv
- Publication Type:In Vitro ; Original Article
- Keywords:
Human adipose-derived mesenchymal stem cells;
Serial passage;
Cell aging;
Relative telomere length;
Subpopulations;
Heterogeneity
- MeSH:
Aging*;
Cell Aging;
Cell Culture Techniques;
Cell Size;
Humans*;
Mesenchymal Stromal Cells*;
Population Characteristics;
Regenerative Medicine;
Serial Passage;
Telomere;
Tissue Donors
- From:International Journal of Stem Cells
2016;9(1):124-136
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND OBJECTIVES: Adipose-derived mesenchymal stem cells (ADSCs) are promising candidates in regenerative medicine. The need for in vitro propagation to obtain therapeutic quantities of the cells imposes a risk of impaired functionality due to cellular senescence. The aim of the study was to analyze in vitro senescence of previously cryopreserved human ADSCs subjected to serial passages in cell culture. METHODS AND RESULTS: ADSC cultures from 8 donors were cultivated until proliferation arrest was reached. A gradual decline of ADSC fitness was observed by altered cell morphology, loss of proliferative, clonogenic and differentiation abilities and increased β-galactosidase expression all of which occurred in a donor-specific manner. Relative telomere length (RTL) analysis revealed that only three tested cultures encountered replicative senescence. The presence of two ADSC subsets with significantly different RTL and cell size was discovered. The heterogeneity of ADSC cultures was supported by the intermittent nature of aging seen in tested samples. CONCLUSION: We conclude that the onset of in vitro senescence of ADSCs is a strongly donor-specific process which is complicated by the intricate dynamics of cell subsets present in ADSC population. This complexity needs to be carefully considered when elaborating protocols for personalized cellular therapy.
